1.
Revenue Model:
No Commissions to Doctors: Meddo doesn't charge doctors, focusing on service margins.
Advantages:
o Attracts more doctors
o Reduces the friction during on boarding already being created by the tech involved
o Encourages Doctors to freely use services and provide best in class treatments
o The margin on services is pretty high – 40% on medicines is a great amount
o Reduces dependency on any doctor as revenue model is standardized
o A much bigger market than consultancy fees
Risks:
o Depends on high transaction volumes
o Potential for over prescription.
o Ethical conflicts might arise for Meddo.
o Big Pharma will fight this change.
o Lots of local resistance in terms of labs and non onboarded doctors.
2. Scaling:
Challenges:
Geographical Coverage: Expanding into new areas requires understanding local healthcare
needs and preferences, which can vary significantly.
Infrastructure Variability: Different regions may have varying levels of healthcare
infrastructure, impacting the delivery and quality of services.
Regulatory Differences: Healthcare regulations can differ widely, necessitating adaptable
strategies to comply with local laws.
Strategies:
Local Expertise: Hiring or partnering with local healthcare professionals can provide valuable
insights into regional needs and preferences.
Diagnostics Partnerships: Collaborating with diagnostics labs can ensure consistent service
quality and broaden the range of available tests.
Technology Investment: Developing robust technology solutions can help navigate
infrastructure challenges and provide scalable services.
Deepening Presence vs. Expansion:
Pros of Deepening Presence:
Solidifies market position by enhancing brand recognition and trust.
Improves service quality through focused improvement and customization.
Cons of Deepening Presence:
Limited growth potential if the market becomes saturated.
Pros of Expansion:
Increases market share by entering new, untapped markets.
Diversifies risk by not relying on a single market for revenue.
Cons of Expansion:
Strains resources, including financial and human capital, potentially impacting
service quality.
May dilute quality if rapid expansion outpaces the ability to maintain high service
standards.
3. Go-To-Market Strategy:
Specialists vs. GPs:
o Favours specialists for higher patient footfall and specialized needs.
o I feel it is better than generalists because of much higher billing in terms of
medicines and tests
o Also the repeat customers of specialists are usually more long term
o Generalists are a much smaller market comparatively
o India there is still a culture of doctors as a luxury, so generalists are not consulted
very often as people wait for problems to get serious.
Conducive Specialties:
o Chronic disease management.
o High diagnostic demand fields.
o Someone like a skin doctor because tests in that field are expensive and unlimited in
number
o Someone like a cardiologist or Kidney specialist because treatment periods are very
elongated with frequent visits.
These align with India's healthcare trends, the most common problems and allows Meddo to
maximize platform utility.